vimarsana.com
Home
Live Updates
Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA : vimarsana.com
Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA : vimarsana.com
Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA
/PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle cell disease treatment, announced today that it has received a Medicine...
Related Keywords
Saudi Arabia ,
United States ,
United Arab Emirates ,
Kuwait ,
India ,
Qatar ,
Bahrain ,
Israel ,
Saudi ,
Kingdom Of Bahrain ,
Americans ,
Kingdom Of Saudi Arabia ,
State Of Qatar ,
George Sekulich ,
Willis Lee ,
Yutaka Niihara ,
Centers For Disease ,
Blueprint For Action National Academy Of Sciences ,
Bahrain National Health Regulatory Authority ,
Emmaus Life Sciences ,
Exchange Commission ,
Committee On Addressing Sickle Cell Disease ,
National Center On Birth Defects ,
Emmaus Life Sciences Inc ,
Company Contact ,
Medicine Registration Certificate ,
Chief Executive Officer ,
Middle East ,
North Africa ,
Senior Vice President ,
Global Commercialization ,
Gulf Pharmacies ,
Life Sciences ,
Prescribing Information ,
Sickle Cell Disease ,
National Center ,
Birth Defects ,
Developmental Disabilities ,
Disease Control ,
Addressing Sickle Cell Disease ,
Strategic Plan ,
Sciences Press ,
Private Securities Litigation Reform Act ,
Operating Officer ,